Related Experiment Videos
Monocyte procoagulant activity in Whipple's disease
Journal of Clinical Immunology
|September 1, 1984
Summary
Patients with active Whipple's disease show spontaneous monocyte prothrombinase activity, a clotting factor not seen after treatment. This suggests monocytes contribute to the disease's pathology.
Area of Science:
- Hematology
- Infectious Diseases
- Pathophysiology
Background:
- Whipple's disease is a rare infectious disease with complex pathophysiology.
- Circulating mononuclear cells play a role in immune responses and coagulation.
- Understanding procoagulant activity in monocytes is crucial for disease insight.
Observation:
- Two of four patients with active Whipple's disease exhibited spontaneous procoagulant activity.
- This activity originated from monocytes and directly cleaved prothrombin, distinct from Factor Xa.
- Monocytes from treated patients or healthy subjects did not display this prothrombinase activity.
Findings:
- Active Whipple's disease is associated with endogenous monocyte stimulation, leading to prothrombinase expression.
- Antibiotic therapy resolved this monocyte prothrombinase activity, correlating with symptom improvement.
- Endotoxin stimulation produced thromboplastin in both patients and controls, indicating a separate pathway.
Implications:
- Circulating monocytes in active Whipple's disease may contribute to the condition's pathophysiology through prothrombinase activity.
- This finding offers a potential therapeutic target for managing Whipple's disease.
- Further research can elucidate the mechanisms of monocyte activation in this disease.